Exogenous supplementation of IPA and IAA has been shown to lower endotoxin levels, inhibit macrophage activation, and suppress the NF-κB signaling pathway, thereby improving liver steatosis and inflammation in a Western diet-induced MASLD mouse model [106]. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.